Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Psychiatry
»
Schizophrenia and Psychotic Disorders
21. April 2026
Search
medline.ch
Schizophrenia and Psychotic Disorders
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Anxiety Disorders
Dementia
Depressive Disorders
Eating Disorders
Personality Disorders
Schizophrenia and Psychotic Disorders
Sleep Disorders
Sexual Disorders
Somatoform Disorders
Substance-Related Disorders
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 3430
Articles 1 - 20 / 68597
Quality of Life in early-phase schizophrenia patients starting treatment with long-acting injectable vs. oral antipsychotic drugs: data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST).
Eur Psychiatry
Schulze AT, Tschiderer L, Post F, Frajo-Apor B, Fleischhacker W, Davidson M, Hofer A.
PMID: 42011073 [PubMed - as supplied by publisher]
A Multidisciplinary Child-Adult Psychiatry Model to Refine the Risk of Psychotic Transition in Clinical High Risk Adolescents: A Clinical Case Study.
Clin Child Psychol Psychiatry
Sibut R, Rhetore L, Besse J, Lachal J.
PMID: 42011015 [PubMed - as supplied by publisher]
Mental health help-seeking by US college students with a diagnosis of psychosis.
Soc Psychiatry Psychiatr Epidemiol
Godoy-Henderson C, Denner SS, Flesaker M, Weinberg J, Dalhoe M, Lipson SK.
PMID: 42010171 [PubMed - as supplied by publisher]
Causal effects of gut microbiota on schizophrenia: deciphering profiles mediated by cerebrospinal fluid metabolites in the gut-brain axis.
World J Biol Psychiatry
Yang Y, Li T, Jing W, Qin W, Yang Q.
PMID: 42008635 [PubMed - as supplied by publisher]
Opportunities for Digital Health to Support Early Psychosis Care in Ghana: Qualitative Study Among Patients, Caregivers, and Clinicians.
JMIR Form Res
Larsen A, Agorinya J, Beaulieu A, Attah DA, Tauscher J, Asafo S, Buck B, Sottie EQ, DeVries E, Okyere AF, Ampaw M, Duah CA, Ofori-Atta A, Obeng K, Ben-Zeev D.
PMID: 42008545 [PubMed - as supplied by publisher]
Impact of abnormal metabolic-immunoinflammatory pathway on splenomegaly in patients with chronic schizophrenia and exploration of risk factors: case-control study.
Front Psychiatry
Shen Y, Wang D, Li Z.
PMID: 42006049 [PubMed]
Validation of the cognitive fusion questionnaire in regular meditators and persons with schizophrenia spectrum disorders.
Front Psychol
Bergmann N, Conell I, Hahne I, Zierhut M, Ta TMT, Hahn E, Böge K.
PMID: 42005019 [PubMed]
Jumping to conclusions and social behavior in individuals diagnosed with schizophrenia.
Schizophr Res Cogn
Hayashi R, Takahama Y, Inadomi H, Ishii R, Watanabe S, Yoshida K, Okada H, Yoshimura M.
PMID: 42004482 [PubMed - as supplied by publisher]
Developmental trajectories of social responsiveness and theory of mind in adolescent offspring at familial high-risk of schizophrenia or bipolar disorder and population-based controls-The Danish High Risk and Resilience Study, VIA 15.
Br J Clin Psychol
Veddum L, Laursen AF, Bundgaard AF, Hemager N, Gregersen M, Krantz MF, Vaskinn A, Jepsen JRM, Sřndergaard A, Rohd SB, Wilms M, Schiavon M, Streymá DHB, Thorup AAE, Nordentoft M, Mors O, Greve AN.
PMID: 42003073 [PubMed - as supplied by publisher]
Metabolic syndrome in chronic schizophrenia: Cross-sectional hospital assessment of prolonged risperidone exposure.
Pak J Pharm Sci
Wu Y, Wu J, Deng Z, Xiao T.
PMID: 42001294 [PubMed - indexed for MEDLINE]
Divergence of C4A and C4B in first-episode psychosis: Insights from CSF and plasma immune profiling.
Transl Psychiatry
Arjmand S, Chaudhary M, Samudyata, Piehl F, Pelanis A, Engberg G, Cervenka S, Landén M, Erhardt S, Sellgren CM.
PMID: 42000733 [PubMed - indexed for MEDLINE]
Task-based fNIRS biomarkers of HD-tDCS treatment for negative symptoms in schizophrenia.
Schizophr Res
Lin CE, Chen LF, Sack AT, Chang HA.
PMID: 42000633 [PubMed - as supplied by publisher]
Cannabis and Tobacco Co-Use is Associated with Impaired Neurocognitive Performance in Individuals at Clinical High Risk for Psychosis.
Biol Psychiatry Cogn Neurosci Neuroimaging
Bello D, Connolly JG, Addington J, Bearden CE, Cadenhead K, Cannon TD, Cornblatt B, Keshavan M, Mathalon DH, Perkins DO, Seidman L, Stone WS, Tsuang MT, Walker EF, Woods S, Brady RO Jr, Carrión RE, Ward HB.
PMID: 41999882 [PubMed - as supplied by publisher]
What are the experiences of people with psychosis, their carers and staff in inpatient mental healthcare services in the United Kingdom? A systematic review and meta-ethnography.
Br J Clin Psychol
MacDonald-Winship LA, Schröder TA, Lane S.
PMID: 41999092 [PubMed - as supplied by publisher]
Cognitive behavioral therapy for insomnia vs. standard cognitive behavioral therapy for sleep and circadian disturbances in treatment-resistant schizophrenia: study protocol for the randomized controlled trial (COSTS).
Trials
Johansen JF, Nielsen MŘ, Kragh M, Nielsen J.
PMID: 41998739 [PubMed - indexed for MEDLINE]
Finding risk factors for dementia in patients with schizophrenia: a population-based case-control study.
BMC Psychiatry
Ho CP, Hsu KL, Chang WC, Hsieh TC.
PMID: 41998529 [PubMed - as supplied by publisher]
Schizophrenia and frontotemporal dementia: distinct diseases with converging circuit dysfunctions.
Neuroscience
Casile A, Sapienza J, Vasciaveo V, Barzon B, Nasini S, Guarato G, Ave C, Martini F, Bosia M, Comai S.
PMID: 41997556 [PubMed - as supplied by publisher]
Perinatal stress as a moderator of the effects of hormonal dysregulation on cognition and symptoms in early psychosis.
Schizophr Res
Gago E, Montalvo I, Cabezas Á, Ortega L, Solé M, Martorell L, Vilella E, García-Rizo C, Labad J.
PMID: 41996952 [PubMed - as supplied by publisher]
Common molecular signatures: the role of BDNF, melatonin, and orexin in the ASD-schizophrenia continuum.
Mol Biol Rep
Alruwaili NS, Al-Kuraishy HM, Al-Gareeb AI, Shokr MM, Bogari NM, Alhelfawi S, Alruwaili M, El-Saber Batiha G.
PMID: 41995757 [PubMed - in process]
Subtle impairments of facial emotion expressions in individuals at ultra-high risk for psychosis.
Front Psychiatry
Kristensen TD, Ebdrup BH, Ambrosen KS, Nordentoft M, Glenthřj LB, Grasshof S.
PMID: 41993838 [PubMed]
Articles 1 - 20 / 68597
Page 1 of 3430
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy